Literature DB >> 25986427

Effects of Fat and Protein Preloads on Pouch Emptying, Intestinal Transit, Glycaemia, Gut Hormones, Glucose Absorption, Blood Pressure and Gastrointestinal Symptoms After Roux-en-Y Gastric Bypass.

Nam Q Nguyen1,2, Tamara L Debreceni3, Carly M Burgstad3, Melissa Neo3, Max Bellon4, Judith M Wishart5, Scott Standfield5, Dylan Bartholomeusz3,4, Chris K Rayner3,5, Gary Wittert5, Michael Horowitz5.   

Abstract

BACKGROUND: The aim was to determine the effects of fat and protein preloads on pouch emptying (PE), caecal arrival time (CAT), glucose absorption, blood glucose (BSL), gut hormones, haemodynamics and gastrointestinal (GI) symptoms in subjects who had undergone Roux-en-Y gastric bypass (RYGB) >12 months previously.
METHODS: Ten RYGB subjects were studied on three occasions, in randomised order, receiving 200-ml preloads of either water, fat (30 ml olive oil) or whey protein (55 g), 30 min before a mixed meal. PE, CAT, BSL, plasma 3-O-methyl-D-glucopyranose (3-OMG), insulin, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1) and glucagon, blood pressure (BP), heart rate (HR) and GI symptoms were assessed over 270 min.
RESULTS: Although fat and protein preloads did not alter PE of either solids or liquids, the CAT of solids, but not liquids, was longer than that after the water preload (fat 68 ± 5 min and protein 71 ± 6 min vs. water 46 ± 5 min; P = 0.02). BSL elevated promptly after the meal on all days (P < 0.001), but after protein, the magnitude and integrated increases in the first 75 min were less than fat and water preloads (area under the curve (AUC(0-75 min)), 18.7 ± 18.2 vs. 107.2 ± 30.4 and 76.1 ± 19.3 mmol/L/min; P < 0.05). Compared to water preload, the protein and fat preloads were associated with greater increases in plasma insulin, GLP-1 and glucagon concentrations, a reduction in BP, and greater increases in HR, fullness, bloating and nausea. Plasma 3-OMG levels were lower after the protein than after the water and fat preloads (P < 0.001).
CONCLUSIONS: Given its effects to attenuate post-prandial glycaemia, reduce intestinal glucose absorption and potentiate the "incretin response", without inducing more adverse post-prandial GI symptom, protein preload may prove clinically useful in RYGB patients and warrant further evaluation, particularly in those with type 2 diabetes (T2DM) and/or dumping syndrome.

Entities:  

Keywords:  Carbohydrate absorption; Fat; Gastrointestinal hormones; Glucose; Post-prandial hyperglycaemia; Preload; Protein; Roux-en-Y gastric bypass

Mesh:

Substances:

Year:  2016        PMID: 25986427     DOI: 10.1007/s11695-015-1722-7

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  37 in total

1.  Inhibition of gastric emptying by sodium oleate depends on length of intestine exposed to nutrient.

Authors:  H C Lin; J E Doty; T J Reedy; J H Meyer
Journal:  Am J Physiol       Date:  1990-12

2.  Effects of intraduodenal glucose concentration on blood pressure and heart rate in healthy older subjects.

Authors:  Diana Gentilcore; Selena Doran; James H Meyer; Michael Horowitz; Karen L Jones
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

3.  A possible role of GLP-1 in the pathophysiology of early dumping syndrome.

Authors:  Hiroshi Yamamoto; Tsuyoshi Mori; Hiroshi Tsuchihashi; Hiroya Akabori; Hiroyuki Naito; Tohru Tani
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

4.  Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.

Authors:  N B Jørgensen; S H Jacobsen; C Dirksen; K N Bojsen-Møller; L Naver; L Hvolris; T R Clausen; B S Wulff; D Worm; D Lindqvist Hansen; S Madsbad; J J Holst
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-04-24       Impact factor: 4.310

5.  Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese men.

Authors:  Ixchel M Brennan; Natalie D Luscombe-Marsh; Radhika V Seimon; Bärbel Otto; Michael Horowitz; Judith M Wishart; Christine Feinle-Bisset
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-03       Impact factor: 4.052

Review 6.  New physiological effects of the incretin hormones GLP-1 and GIP.

Authors:  Meena Asmar
Journal:  Dan Med Bull       Date:  2011-02

7.  Nutrient feedback inhibition of gastric emptying plays a larger role than osmotically dependent duodenal resistance.

Authors:  H C Lin; J D Elashoff; Y G Gu; J H Meyer
Journal:  Am J Physiol       Date:  1993-10

8.  Effects of exogenous glucagon-like peptide-1 on the blood pressure, heart rate, mesenteric blood flow, and glycemic responses to intraduodenal glucose in healthy older subjects.

Authors:  Laurence G Trahair; Michael Horowitz; Trygve Hausken; Christine Feinle-Bisset; Christopher K Rayner; Karen L Jones
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

9.  Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes.

Authors:  Jing Ma; Julie E Stevens; Kimberly Cukier; Anne F Maddox; Judith M Wishart; Karen L Jones; Peter M Clifton; Michael Horowitz; Christopher K Rayner
Journal:  Diabetes Care       Date:  2009-06-18       Impact factor: 19.112

10.  Glucose absorption and gastric emptying in critical illness.

Authors:  Marianne J Chapman; Robert J L Fraser; Geoffrey Matthews; Antonietta Russo; Max Bellon; Laura K Besanko; Karen L Jones; Ross Butler; Barry Chatterton; Michael Horowitz
Journal:  Crit Care       Date:  2009-08-27       Impact factor: 9.097

View more
  8 in total

1.  Heterogeneity in the Definition and Clinical Characteristics of Dumping Syndrome: a Review of the Literature.

Authors:  Ben Gys; Philip Plaeke; Bas Lamme; Thierry Lafullarde; Niels Komen; Anthony Beunis; Guy Hubens
Journal:  Obes Surg       Date:  2019-06       Impact factor: 4.129

2.  Gastrointestinal pH, Motility Patterns, and Transit Times After Roux-en-Y Gastric Bypass.

Authors:  Louise Ladebo; Pernille V Pedersen; Grzegorz J Pacyk; Jens Peter Kroustrup; Asbjørn M Drewes; Christina Brock; Anne E Olesen
Journal:  Obes Surg       Date:  2021-03-12       Impact factor: 4.129

Review 3.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

4.  Insights from the Impact of Meal Composition on Glucose Profile Towards Post-bariatric Hypoglycemia Management.

Authors:  Ana Raquel Marques; Carolina B Lobato; Sofia S Pereira; Marta Guimarães; Sandra Faria; Mário Nora; Mariana P Monteiro
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

Review 5.  Medical nutrition therapy for post-bariatric hypoglycemia: practical insights.

Authors:  Emmy Suhl; Sue-Ellen Anderson-Haynes; Christopher Mulla; Mary-Elizabeth Patti
Journal:  Surg Obes Relat Dis       Date:  2017-01-16       Impact factor: 4.734

6.  Development of a delayed-release nutrient for appetite control in adults with obesity and type 2 diabetes and initial clinical testing in a single dose randomized controlled trial.

Authors:  E Beale; E Lim; H Yassine; C Azen; C Christopher
Journal:  Nutr Diabetes       Date:  2019-07-15       Impact factor: 5.097

7.  Do Body Composition and Values of Selected Nutritional Status Indices Influence the Glycaemic Index Values of Vegetarian Dishes? A Pilot Study in a Group of Older Women.

Authors:  Ewa Raczkowska; Maciej Bienkiewicz; Robert Gajda; Monika Bronkowska; Ewa Piotrowska; Marta Habánová
Journal:  Int J Environ Res Public Health       Date:  2022-08-11       Impact factor: 4.614

8.  Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.

Authors:  Anne Christin Meyer-Gerspach; Lucian Cajacob; Daniele Riva; Raphael Herzog; Juergen Drewe; Christoph Beglinger; Bettina K Wölnerhanssen
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.